Wave Life Sciences Ltd. (WVE) — Analyst outlook / Analyst consensus target is. Based on 25 analyst ratings, the consensus is bullish — 1 Strong Buy, 23 Buy, 1 Hold.
The consensus price target is $32.50 (low: $26.00, high: $50.00), representing an upside of 339.8% from the current price $7.39.
Analysts estimate Earnings Per Share (EPS) of $-1.14 and revenue of $0.05B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-0.70 vs est $-1.14 (beat +38.4%). 2025: actual $-1.21 vs est $-1.19 (missed -1.5%). Analyst accuracy: 68%.
WVE Stock — 12-Month Price Forecast
$32.50
▲ +339.78% Upside
Average Price Target
Based on 25 Wall Street analysts offering 12-month price targets for Wave Life Sciences Ltd., the average price target is $32.50, with a high forecast of $50.00, and a low forecast of $26.00.
The average price target represents a +339.78% change from the last price of $7.39.
Highest Price Target
$50.00
Average Price Target
$32.50
Lowest Price Target
$26.00
WVE Analyst Ratings
Buy
Based on 25 analysts giving stock ratings to Wave Life Sciences Ltd. in the past 3 months
EPS Estimates — WVE
68%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024
Actual –$0.70
vs Est –$1.14
▲ 62.4% off
2025
Actual –$1.21
vs Est –$1.19
▼ 1.5% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — WVE
73%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024
Actual $0.108B
vs Est $0.054B
▲ 50.1% off
2025
Actual $0.043B
vs Est $0.041B
▲ 4.0% off
Revenue Trend
Revenue has declined over the period shown. Analysts forecast significant revenue growth ahead.
